A DOSE-ESCALATION STUDY OF HIGH-DOSE INTERFERON-ALPHA 2A (HDIFN) UP TO 18 MILLION UNITS DAILY IN PATIENTS WITH POOR-PROGNOSIS CHRONIC MYELOID-LEUKEMIA (CML) OR GOOD PROGNOSIS PATIENTS WHO HAVE FAILED TREATMENTWITH IFN PLUS CYTOSINE-ARABINOSIDE (ARA-C)

Citation
Ck. Arthur et al., A DOSE-ESCALATION STUDY OF HIGH-DOSE INTERFERON-ALPHA 2A (HDIFN) UP TO 18 MILLION UNITS DAILY IN PATIENTS WITH POOR-PROGNOSIS CHRONIC MYELOID-LEUKEMIA (CML) OR GOOD PROGNOSIS PATIENTS WHO HAVE FAILED TREATMENTWITH IFN PLUS CYTOSINE-ARABINOSIDE (ARA-C), Blood, 88(10), 1996, pp. 2291-2291
Citations number
NO
Categorie Soggetti
Hematology
Journal title
BloodACNP
ISSN journal
00064971
Volume
88
Issue
10
Year of publication
1996
Part
1
Supplement
1
Pages
2291 - 2291
Database
ISI
SICI code
0006-4971(1996)88:10<2291:ADSOHI>2.0.ZU;2-S